Contact this trialFirst, we need to learn more about you.
Alkylating agents
Olaparib for Ovarian and Peritoneal Cancer
Recruiting1 awardPhase < 1
Houston, Texas
This trial is testing olaparib to see if it can stop the growth of cancer cells in patients with BRCA-mutant ovarian, primary peritoneal, or fallopian cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.